Cannabis' Federal Legal Status Is Not a Total Buzzkill
The industry still has significant growth potential.
Karen Wallace: Hi, I'm Karen Wallace from Morningstar. There's a lot of talk about cannabis these days. U.S. Senate Democrats recently released a discussion draft of a bill that would deschedule cannabis on a federal level and recognize states' individual cannabis laws. Though cannabis is legal or set to become legal for both recreational and medical use in 19 states and medical use only in another 17 states, it's still illegal on a federal level. And that uncertainty has clouded this growing industry. I'm here with Kris Inton. He's an equity research strategist for ESG at Morningstar. Kris, what difference would it make if cannabis were no longer illegal on a federal level?
Kristoffer Inton: The removal of federal prohibition would be a massive boon to the industry, especially financially. First, at present, any industry that does business with or serves the cannabis industry could be considered aiding and abetting criminal activity. The ability to access financial services is one of the most notable limitations. U.S. cannabis companies are neither listed on major U.S. stock exchanges nor fully served by banks. So, change to federal law would open these up for the industry. Second, due to IRS laws, U.S. cannabis companies pay very high tax rates, as they're technically a federally illegal business. The removal of prohibition would bring rates into the 20% territory that every other industry pays. And then lastly, scientific research would be easier to conduct, including any studies on efficacy, potency, and safety. And this can help remove a lot of the misconceptions that have lingered.
Karen Wallace does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
We’d like to share more about how we work and what drives our day-to-day business.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
To learn more about how we handle and protect your data, visit our privacy center.
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.
To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.
Read our editorial policy to learn more about our process.